FUZULOPARIB

Investigational

Details

Stereochemistry	ACHIRAL
Molecular Formula	C22H16F4N6O2
Molecular Weight	472.3951
Optical Activity	NONE
Defined Stereocenters	0 / 0
E/Z Centers	0
Charge	0

SHOW SMILES / InChI

Structure Search

SMILES

FC1=CC=C(CC2=NNC(=O)C3=CC=CC=C23)C=C1C(=O)N4CCN5N=C(N=C5C4)C(F)(F)F

InChI

InChIKey=XJGXCBHXFWBOTN-UHFFFAOYSA-N

InChI=1S/C22H16F4N6O2/c23-16-6-5-12(10-17-13-3-1-2-4-14(13)19(33)29-28-17)9-15(16)20(34)31-7-8-32-18(11-31)27-21(30-32)22(24,25)26/h1-6,9H,7-8,10-11H2,(H,29,33)

HIDE SMILES / InChI

Molecular Formula	C22H16F4N6O2
Molecular Weight	472.3951
Charge	0
Count

Stereochemistry	ACHIRAL
Additional Stereochemistry	No
Defined Stereocenters	0 / 0
E/Z Centers	0
Optical Activity	NONE

Approval Year

C_max

Value	Dose	Co-administered	Analyte	Population
1140.16 ng/mL CLINICAL TRIAL https://bpspubs.onlinelibrary.wiley.com/doi/epdf/10.1111/bcp.14926	50 mg single, oral dose: 50 mg route of administration: Oral experiment type: SINGLE co-administered:		FLUZOPARIB plasma	Homo sapiens population: HEALTHY age: ADULT sex: MALE food status: UNKNOWN
373.29 ng/mL CLINICAL TRIAL https://bpspubs.onlinelibrary.wiley.com/doi/epdf/10.1111/bcp.14926	50 mg single, oral dose: 50 mg route of administration: Oral experiment type: SINGLE co-administered: rifampicin	rifampicin	FLUZOPARIB plasma	Homo sapiens population: HEALTHY age: ADULT sex: MALE food status: UNKNOWN
2.26 μg/mL CLINICAL TRIAL https://www.tandfonline.com/doi/full/10.1080/17425255.2021.1881480	120 mg single, oral dose: 120 mg route of administration: Oral experiment type: SINGLE co-administered:		FLUZOPARIB plasma	Homo sapiens population: HEALTHY age: ADULT sex: MALE food status: FED
2.76 μg/mL CLINICAL TRIAL https://www.tandfonline.com/doi/full/10.1080/17425255.2021.1881480	120 mg single, oral dose: 120 mg route of administration: Oral experiment type: SINGLE co-administered:		FLUZOPARIB plasma	Homo sapiens population: HEALTHY age: ADULT sex: MALE food status: FASTED
2395.17 ng/mL CLINICAL TRIAL https://link.springer.com/article/10.1007/s10637-020-01034-w	100 mg single, oral dose: 100 mg route of administration: Oral experiment type: SINGLE co-administered:		FLUZOPARIB plasma	Homo sapiens population: HEALTHY age: ADULT sex: MALE food status: FED
2489.42 ng/mL CLINICAL TRIAL https://link.springer.com/article/10.1007/s10637-020-01034-w	100 mg single, oral dose: 100 mg route of administration: Oral experiment type: SINGLE co-administered: Omeprazole	Omeprazole	FLUZOPARIB plasma	Homo sapiens population: HEALTHY age: ADULT sex: MALE food status: FED

AUC

Value	Dose	Co-administered	Analyte	Population
11617.82 ng × h/mL CLINICAL TRIAL https://bpspubs.onlinelibrary.wiley.com/doi/epdf/10.1111/bcp.14926	50 mg single, oral dose: 50 mg route of administration: Oral experiment type: SINGLE co-administered:		FLUZOPARIB plasma	Homo sapiens population: HEALTHY age: ADULT sex: MALE food status: UNKNOWN
1232.79 ng × h/mL CLINICAL TRIAL https://bpspubs.onlinelibrary.wiley.com/doi/epdf/10.1111/bcp.14926	50 mg single, oral dose: 50 mg route of administration: Oral experiment type: SINGLE co-administered: rifampicin	rifampicin	FLUZOPARIB plasma	Homo sapiens population: HEALTHY age: ADULT sex: MALE food status: UNKNOWN
30.5 μg × h/mL CLINICAL TRIAL https://www.tandfonline.com/doi/full/10.1080/17425255.2021.1881480	120 mg single, oral dose: 120 mg route of administration: Oral experiment type: SINGLE co-administered:		FLUZOPARIB plasma	Homo sapiens population: HEALTHY age: ADULT sex: MALE food status: FED
33.1 μg × h/mL CLINICAL TRIAL https://www.tandfonline.com/doi/full/10.1080/17425255.2021.1881480	120 mg single, oral dose: 120 mg route of administration: Oral experiment type: SINGLE co-administered:		FLUZOPARIB plasma	Homo sapiens population: HEALTHY age: ADULT sex: MALE food status: FASTED
26897.44 ng × h/mL CLINICAL TRIAL https://link.springer.com/article/10.1007/s10637-020-01034-w	100 mg single, oral dose: 100 mg route of administration: Oral experiment type: SINGLE co-administered:		FLUZOPARIB plasma	Homo sapiens population: HEALTHY age: ADULT sex: MALE food status: FED
30678.74 ng × h/mL CLINICAL TRIAL https://link.springer.com/article/10.1007/s10637-020-01034-w	100 mg single, oral dose: 100 mg route of administration: Oral experiment type: SINGLE co-administered: Omeprazole	Omeprazole	FLUZOPARIB plasma	Homo sapiens population: HEALTHY age: ADULT sex: MALE food status: FED

T_1/2

Value	Dose	Co-administered	Analyte	Population
10.83 h CLINICAL TRIAL https://bpspubs.onlinelibrary.wiley.com/doi/epdf/10.1111/bcp.14926	50 mg single, oral dose: 50 mg route of administration: Oral experiment type: SINGLE co-administered:		FLUZOPARIB plasma	Homo sapiens population: HEALTHY age: ADULT sex: MALE food status: UNKNOWN
2.1 h CLINICAL TRIAL https://bpspubs.onlinelibrary.wiley.com/doi/epdf/10.1111/bcp.14926	50 mg single, oral dose: 50 mg route of administration: Oral experiment type: SINGLE co-administered: rifampicin	rifampicin	FLUZOPARIB plasma	Homo sapiens population: HEALTHY age: ADULT sex: MALE food status: UNKNOWN
13 h CLINICAL TRIAL https://www.tandfonline.com/doi/full/10.1080/17425255.2021.1881480	120 mg single, oral dose: 120 mg route of administration: Oral experiment type: SINGLE co-administered:		FLUZOPARIB plasma	Homo sapiens population: HEALTHY age: ADULT sex: MALE food status: FED
11.8 h CLINICAL TRIAL https://www.tandfonline.com/doi/full/10.1080/17425255.2021.1881480	120 mg single, oral dose: 120 mg route of administration: Oral experiment type: SINGLE co-administered:		FLUZOPARIB plasma	Homo sapiens population: HEALTHY age: ADULT sex: MALE food status: FASTED
10.38 h CLINICAL TRIAL https://link.springer.com/article/10.1007/s10637-020-01034-w	100 mg single, oral dose: 100 mg route of administration: Oral experiment type: SINGLE co-administered:		FLUZOPARIB plasma	Homo sapiens population: HEALTHY age: ADULT sex: MALE food status: FED
11.55 h CLINICAL TRIAL https://link.springer.com/article/10.1007/s10637-020-01034-w	100 mg single, oral dose: 100 mg route of administration: Oral experiment type: SINGLE co-administered: Omeprazole	Omeprazole	FLUZOPARIB plasma	Homo sapiens population: HEALTHY age: ADULT sex: MALE food status: FED

Substance Class	Chemical Created by `admin` on `Wed Apr 02 02:34:18 GMT 2025` Edited by `admin` on `Wed Apr 02 02:34:18 GMT 2025`
Record UNII	TWF0ML1CK8
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

HS-10160

Preferred Name

English

FUZULOPARIB

Official Name

English

SHR3162

Code

English

4-((3-((5,6-DIHYDRO-2-(TRIFLUOROMETHYL)(1,2,4)TRIAZOLO(1,5-A)PYRAZIN-7(8H)-YL)CARBONYL)-4-FLUOROPHENYL)METHYL)-1(2H)-PHTHALAZINONE

Systematic Name

English

FLUZOPARIB

Common Name

English

1(2H)-PHTHALAZINONE, 4-((3-((5,6-DIHYDRO-2-(TRIFLUOROMETHYL)(1,2,4)TRIAZOLO(1,5-A)PYRAZIN-7(8H)-YL)CARBONYL)-4-FLUOROPHENYL)METHYL)-

Systematic Name

English

fuzuloparib [INN]

Common Name

English

Fluzoparib [WHO-DD]

Common Name

English

FUZUOPALI

Common Name

English

SHR-3162

Code

English

HS10160

Code

English

Code System Code Type Description

DRUG BANK

DB15637